Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Halving dose of Preveon does not reduce its efficacy in HIV

March 29, 1999

Combination therapy with delavirdine and zidovudine in AIDS

March 18, 1999

In vivo function, migration of CTLs in HIV immunotherapy

March 17, 1999

HIV protease-activated Casp3 protein specifically targets infected cells

March 17, 1999

New AZT derivatives with improved anti-HIV activity presented by Hughes Institute

March 16, 1999

Hollis-Eden to initiate HIV/AIDS trials with HE-2000 in South Africa

March 15, 1999

Procept's PRO-2000 Gel shows positive results in protection from HIV infection

March 12, 1999

Improved non-nucleoside HIV-1 RT inhibitors in development at Boehringer Ingelheim

March 11, 1999

Boehringer Ingelheim discloses novel series active against wild-type and mutant HIV-1 RT

March 10, 1999

Sustiva recommended for full marketing approval in Europe

March 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...